42 results
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
12 Nov 24
Regulation FD Disclosure
6:56am
. “This milestone is the culmination of many years of hard work, the foundational work by our partners at UCL and the unwavering commitment of our internal team, our
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
5 Jun 24
Registered Number 11185179 (England & Wales) Annual Report and financial statements for the year ended 31 December 2023 for Autolus Therapeutics plc
4:35pm
organisation consistent with our purpose and values. Our commitment is to the development of individuals, our teams and the organisation as a whole … managers of the Group 9 2 11 All employees of the Group 239 221 460 Total Employees 255 226 481 Anti-bribery The Group has made a commitment to carry out
10-K
14jostaubqbyjenr
21 Mar 24
Annual report
4:55pm
8-K
EX-1.1
bkk928mueg4qcpoay
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
hco5lpd y8yx9y1m
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-99.1
o9r rj9by977c
27 Nov 23
Regulation FD Disclosure
7:07am
10-Q
EX-10.2
07kmzi54ei
9 Nov 23
Quarterly report
4:18pm
6-K
EX-1.1
42iv6y9b60tyv8l zq
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1
e2sw7n7lpi
1 Jul 22
Current report (foreign)
5:15pm
6-K
EX-99.4
20ixegj 74ikuz
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-99.1
e4i26nibnm0vt qyws
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1
hzs7296m6m1bmr
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1.1
fop27f
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm